1. Materials and reagents. All chemicals were purchased from Sigma-Aldrich and were used as acquired.
Pam 3 CSK 4 (N-palmitoyl-S- [2,3- 
bis(palmitoyloxy)-(2RS)-propyl]-[R]-cysteinyl-[S]-seryl-[S]-lysyl-[S]-lysyl-[S]-lysyl-[S]
-l ysine.3HCl) and rhodamine-labeled Pam 3 CSK 4 were purchased from InvivoGen (San Diego, CA, USA). Lipofectamine ® 2000 was purchased from Invitrogen (Carlsbad, CA, USA). pNF-κB-luc reporter gene was purchased from Beyotime (Beyotime, Shanghai, China). pRL-TK vector and dualluciferase reporter assay system were obtained from Promega Corporation (Madison, WI, USA). pZERO-TLR1 was purchased from InvivoGen (San Diego, CA) and pCMV-Flag-TLR2 was purchased from
Addgene. Antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All compounds with the purity of 92-98% were purchased from InterBioScreen (Moscow, Russia) and dissolved in dimethyl sulfoxide (DMSO).
Molecular docking and virtual screening.
Model construction. The initial model of TLR1/2 was derived from the X-ray crystal structure of the TLR1/2
heterodimer co-crystallized with the a tri-acylated lipopeptide (PDB: 2Z7X), 1 using the molecular conversion procedure implemented in the ICM-pro 3.6-1d program (Molsoft). 2 The molecular conversion procedure implemented in ICM-pro 3.6-1d program can read, build, convert, refine, analyze and superimpose molecules, plus provide target evaluation to generate three dimensional models. Hydrogen and missing heavy atoms were added to the receptor structure, also atom types and partial charges were assigned. The model was then subjected to local energy minimization to identify the optimal position by using the ICM biased probability Monte Carlo algorithm 3 and analytical derivatives in the internal coordinates. The optimization gradient was 45 kcal/mol/Å 3 .
High throughput molecular docking. A chemical library containing over 90,000 natural product or natural product-like compounds (ZINC natural product database) was docked to the molecular model of TLR1/2 in silico. Molecular docking was performed using the virtual library screening (VLS) module in the ICM-Pro 3.6-1d program (Molsoft). In the ICM fast docking and VLS procedure, the receptor all-atom model was converted into energy potential maps calculated on a fine 3D grid (0.5 Å cell). The grid potential maps account for van der Waals, hydrogen-bonding, hydrophobic, and electrostatic interactions between ligand and receptor. The search area for molecular docking was restricted to the interaction domain of TLR1/2. Each compound in the library was assigned the MMFF 4 force field atom types and charges then subjected to Cartesian minimization. During the docking analysis, the ligand was represented by an all-atom model and considered fully flexible in the potential field of the receptor, the binding pose and internal torsions were sampled by the BPMC minimization procedure, which involved local energy minimization after each random move. Each compound was docked to the protein complex binding pocket and a score from the docking was assigned to each compound according to the weighed component of the ICM scoring function (see below).
Each compound was docked three times to ensure the convergence of the Monte Carlo optimization, and the minimum score of each ligand from the three independent docking experiments was retained and used for ranking. The docking procedure takes about 30 s of time per compound on an Intel Xeon 2.8 GHz CPU using a 100 processor Linux cluster. A permissive cut-off score of -30.0 was chosen in order to weed out lowaffinity ligands and to reduce the number of compounds tested in vitro. 17 compounds were purchased for in vitro biological testing.
ICM full-atom ligand-receptor complex refinement and scoring. Once the ligand-receptor complexes are generated by molecular docking, they have to be subjected to complex refinement and scoring. According to the ICM method, 5 the molecular system was described using internal coordinates as variables. Energy calculations were based on the ECEPP/3 force field with a distance-dependent dielectric constant. The biased electrostatic energy, (vi) hydrophobic energy and (vii) hydrogen bond donor or acceptor desolvation. The lower the ICM score, the higher the chance the ligand is a binder. The score was calculated by:
whereas E vw , E el , E hb , E hp , and E sf are van der Waals, electrostatic, hydrogen bonding, and nonpolar and polar atom solvation energy differences between bound and unbound states, respectively. E int is the ligand internal strain, ΔS Tor is its conformational entropy loss upon binding, and T = 300 K, and α i are ligand-and receptor independent constants. containing 10% fetal bovine serum (FBS), penicillin (100 U/mL) and streptomycin (100 mg/mL), incubated at 37 °C in a 5% CO 2 humidified incubator, and passaged three times a week. The absorbance was monitored in SpectraMax M5 microplate reader at 490 nm and 600 nm.
Statistical analysis.
For statistical analysis, all data were analyzed with one-way analysis of variance (ANOVA) followed by the Dunnett's method for multiple comparisons by using GraphPad Prism 6.0. A significant difference was defined as P < 0.05. 
